Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre,...
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
About this item
Full title
Author / Creator
Muro, Kei, Dr , Chung, Hyun Cheol, Prof , Shankaran, Veena, MD , Geva, Ravit, MD , Catenacci, Daniel, MD , Gupta, Shilpa, MD , Eder, Joseph Paul, MD , Golan, Talia, MD , Le, Dung T, MD , Burtness, Barbara, MD , McRee, Autumn J, MD , Lin, Chia-Chi, MD , Pathiraja, Kumudu, MA , Lunceford, Jared, PhD , Emancipator, Kenneth, MD , Juco, Jonathan, MD , Koshiji, Minori, MD and Bang, Yung-Jue, Prof
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Expression of PD-L1 has been shown to be upregulated in some patients with gastric cancer. As part of the phase 1b KEYNOTE-012 study, we aimed to assess the safety and activity of the anti-PD-1 antibody pembrolizumab in patients with PD-L1-positive recurrent or metastatic adenocarcinoma of the stomach or gastro-oesophageal juncti...
Alternative Titles
Full title
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Authors, Artists and Contributors
Author / Creator
Chung, Hyun Cheol, Prof
Shankaran, Veena, MD
Geva, Ravit, MD
Catenacci, Daniel, MD
Gupta, Shilpa, MD
Eder, Joseph Paul, MD
Golan, Talia, MD
Le, Dung T, MD
Burtness, Barbara, MD
McRee, Autumn J, MD
Lin, Chia-Chi, MD
Pathiraja, Kumudu, MA
Lunceford, Jared, PhD
Emancipator, Kenneth, MD
Juco, Jonathan, MD
Koshiji, Minori, MD
Bang, Yung-Jue, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1797541569
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1797541569
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(16)00175-3
